A second-generation, self-amplifying COVID-19 Vaccine: World’s first approval and distribution in the Japanese market with vaccine hesitancy
The mRNA vaccine is a milestone in immunotherapeutics, as symbolized by the 2023 Nobel Prize for Physiology or Medicine awarded to Drs. Karikó and Weissman. Whereas the conventional, “first-generation” mRNA vaccine was globally distributed to hundreds of millions of people to decrease COVID-19 preva...
Saved in:
Main Author: | Toshio Naito |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2025.2530291 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Circular RNA vaccines: Pioneering the next-gen cancer immunotherapy
by: Uddalak Das, et al.
Published: (2025-07-01) -
Immunogenicity of DNA, mRNA and Subunit Vaccines Against Beak and Feather Disease Virus
by: Buyani Ndlovu, et al.
Published: (2025-07-01) -
A novel combined quadrivalent self-amplifying mRNA-LNP vaccine provokes protective immunity against acute and chronic toxoplasmosis in mice
by: Qinli Wu, et al.
Published: (2025-06-01) -
Research progress on the quality control of mRNA vaccines
by: Chaoying Hu, et al.
Published: (2024-12-01) -
The mRNA vaccine, a swift warhead against a moving infectious disease target
by: Sheema Mir, et al.
Published: (2024-12-01)